Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1988;35(3):323-6.
doi: 10.1007/BF00558273.

Inhibition of the aldosterone response to sodium depletion in man by stimulation of dopamine DA2 receptors

Affiliations
Clinical Trial

Inhibition of the aldosterone response to sodium depletion in man by stimulation of dopamine DA2 receptors

C Lombardi et al. Eur J Clin Pharmacol. 1988.

Abstract

In this study we have investigated the effect of co-dergocrine, a selective DA2-agonist, on plasma aldosterone concentrations (PAC) in twelve patients with essential hypertension both in basal conditions and during sodium depletion. Sodium depletion resulted in an increase of PAC from 38 (13) pg/ml to 297 (21) pg/ml. The PAC response to sodium depletion was reduced to 155 (29) pg/ml by co-dergocrine. No significant PAC changes were found in patients maintained on a normal sodium intake. In addition the drug did not significantly modify plasma renin activity (PRA) in either experimental group. These results suggest that the dopaminergic inhibition of aldosterone secretion in man is mediated by DA2 receptors in the adrenal cortex.

PubMed Disclaimer

References

    1. Life Sci. 1985 Dec 30;37(26):2539-48 - PubMed
    1. Endocrinology. 1986 Nov;119(5):2227-32 - PubMed
    1. Clin Endocrinol (Oxf). 1980 Jul;13(1):45-50 - PubMed
    1. J Clin Endocrinol Metab. 1986 Jul;63(1):197-201 - PubMed
    1. Endocrinology. 1985 Nov;117(5):1947-52 - PubMed

Publication types

LinkOut - more resources